IntelliPharmaCeutics International Inc. filed its 20-F on Jan 31, 2013 for the period ending Nov 30, 2012. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.